GRAPPA患者研究パートナーネットワークの構成と関与:成長のための戦略的分野を決定する調査
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。牛皮病と牛皮病関節炎の研究と評価のためのグループ (GRAPPA) 患者研究パートナー (PRP) ネットワークの調査は,ジェンダーの平等と長期参加の強みを特定しました. 世界的な代表性を向上させるため,より大きな民族的,地理的な多様性の必要性を強調した.
科学分野
- リウマトロジ
- 患者中心の研究
- 牛皮病の研究
背景
- 牛皮病と牛皮病関節炎の研究と評価のためのグループ (GRAPPA) の患者研究パートナー (PRP) ネットワークは,グローバルな範囲と代表性を向上させることを目的としています.
- 戦略的成長には,現在のネットワークの 人口統計と関与を理解することが不可欠です.
研究 の 目的
- GRAPPAの患者研究パートナー (PRP) ネットワークを調査し,強みと欠点を特定する.
- ネットワーク内のグローバルな代表性と多様性を向上させるための戦略を策定する.
主な方法
- GRAPPAのPRPネットワークのメンバーを対象に調査が行われました.
- データ分析は,人口統計,参加,および認識されたネットワークの特徴に焦点を当てました.
主要な成果
- この調査は,PRPメンバーの間で強いジェンダー・パリティと長期的なプロジェクト参加率を明らかにした.
- 民族的・地理的多様性を増やす必要があることが明らかになった.
- 現状のネットワーク構成は,不足している地域や年齢層を含むように拡張する必要があります.
結論
- GRAPPAのPRPネットワークは,代表が少ない地域 (アフリカ,アジア,オーストラリア/ニュージーランド,南米,東欧) から積極的にパートナーを募集し,年齢層を広げなければなりません.
- 対象を絞った採用活動により,多様性が高められ,GRAPPAの研究目標が進みます.
- この調査結果は,GRAPPA 2024の年次総会で発表され,将来の取り組みの指針となる.
関連する概念動画
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...